You can buy or sell Forty Seven and other stocks, options, ETFs, and crypto commission-free!
Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. Read More The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.
Menlo Park, California
52 Week High
52 Week Low
Yahoo FinanceMay 13
Forty Seven Inc. Reports First Quarter 2019 Financial Results and Recent Business Highlights
-- Updated Data from Phase 1b/2 Trial of 5F9 in Combination with Rituximab in r/r NHL to be Presented at EHA and ICML in June -- – Updated Data from Phase 1b Trial of 5F9 as Monotherapy and in Combination with Azacitidine in AML and MDS to be Presented at ASCO and EHA in June -- -- Entered into Collaborations with Roche/Genentech and AstraZeneca/Acerta to Evaluate Two Triplet Regimens in NHL -- -- Management to Host Conference Call at 4:30 p.m. ET Today -- MENLO PARK, Calif., May 13, 2019 (GLOBE N...
Yahoo FinanceMay 13
Forty Seven, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 13, 2019 / Forty Seven, Inc. (NASDAQ: FTSV) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 13, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-EDEC062026DBF To receive updates for this company you can register by emailing email@example.com or by clicking get investment info from the company's profile. About Investor Network In...
Markets InsiderMay 6
Forty Seven Inc. to Report First Quarter 2019 Financial Results on Monday, May 13, 2019
MENLO PARK, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that it will host a live conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on Monday, May 13, 2019 to report its first quarter 2019 financial results and provide a corporate update. The live call may be accessed by dialing (866) 953-0780 for domestic callers or (630) 652-...
-$0.63 per share
-$0.74 per share